Singular Genomics Systems, Inc. Common Stock
OMIC
OMIC was delisted on the 20th of February, 2025.
20 hedge funds and large institutions have $21.5M invested in Singular Genomics Systems, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
17% more capital invested
Capital invested by funds: $18.4M → $21.5M (+$3.12M)
3.24% less ownership
Funds ownership: 47% → 43.76% (-3.2%)
9% less funds holding
Funds holding: 22 → 20 (-2)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.45M |
| 2 |
PCM
PenderFund Capital Management
Vancouver,
British Columbia, Canada
|
+$39.1K |
| 3 |
JP Morgan Chase
New York
|
+$32.8K |
| 4 |
Morgan Stanley
New York
|
+$29.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$16.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CL
CRCM LP
San Francisco,
California
|
-$1.58M |
| 2 |
PA
Perceptive Advisors
New York
|
-$798K |
| 3 |
BlackRock
New York
|
-$10.6K |
| 4 |
DWS
Dynamic Wealth Strategies
Granite Bay,
California
|
-$1K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$37 |
OMIC Hedge Fund Activity: Q4 2024 in Review
20 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q4 2024, worth a combined $21.5M — up 17% from $18.4M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of OMIC and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 6 added.
The largest buyer was UBS Group, adding an estimated $1.45M. The largest seller was CRCM LP, exiting entirely with an estimated $1.58M sold.
- 20 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q4 2024, down from 22 in Q3 2024.
- Funds reported $21.5M of Singular Genomics Systems, Inc. Common Stock stock for Q4 2024, up 17% quarter-over-quarter.
- 1 fund opened new Singular Genomics Systems, Inc. Common Stock positions in Q4 2024 and 3 closed out, a net change of -2 holders.
- The largest Singular Genomics Systems, Inc. Common Stock buyer in Q4 2024 was UBS Group, an estimated $1.45M added.
- The largest Singular Genomics Systems, Inc. Common Stock seller in Q4 2024 was CRCM LP, an estimated $1.58M sold.
Based on aggregated 13F filings for Q4 2024.